We found that sera from most MG patients (5 out of 6 SPMG and 6 out of 6 SNMG) induced a significant increase in IL-6 production (p < 0.005 for the entire group of MG patients) when normalized to the production by cells treated with sera from age-matched controls. Here, IL6 is linked to myasthenia gravis.